Cataplexy Market Size, Epidemiology, Leading Companies, Drugs and Competitive Analysis by DelveInsight | Axsome Therapeutics, Takeda, Avadel, Others

Cataplexy is a sudden and uncontrollable muscle weakness or paralysis that comes on during the day and is often triggered by a strong emotion, such as excitement or laughter. The vast majority of people who experience cataplexy do so as a result of having type 1 narcolepsy, a chronic sleep and neurological disorder in which the brain has trouble properly controlling wake and sleep cycles. In very rare cases, cataplexy has been reported in individuals without narcolepsy. The cause of this circumstance remains unknown.

DelveInsight's Cataplexy Market Insights, Epidemiology, and Market Forecast-2030 report delivers an in-depth understanding of the Cataplexy, historical and forecasted epidemiology as well as the Cataplexy market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

Some facts of Cataplexy Market are:

·         Mirabile and Sharma (2020) in the study titled “Cataplexy”, stated that in the US, narcolepsy affects 1 in 2000 individuals with an equal distribution amongst the sexes. As per the study, symptom onset most frequently occurs during adolescence; however, diagnosis often gets delayed on average by 15 years. The study also highlights that there are two forms of narcolepsy, namely, type 1 which is associated with cataplexy while this feature is absent in type 2.

·         In the US, type 1 narcolepsy affects 1 to 2 in 4000 individuals.

·         The study titled “The Prevalence and Characteristics of Primary Headache and Dream-Enacting Behaviour in Japanese Patients with Narcolepsy or Idiopathic Hypersomnia: A Multi-Centre Cross-Sectional Study” by Suzuki et al., (2015) suggested that the prevalence of narcolepsy with cataplexy has been estimated to range from 0.16% to 0.18% in Japan, while narcolepsy without cataplexy represents from 15% to 25% of the clinical narcoleptic population.

·         The prevalence of cataplexy has been reported in up to 29% of young adults with associated excessive daytime sleepiness. However, the prevalence of isolated cataplexy is unknown.

·         Secondary cataplexy refers to the characteristic episodes of sudden muscle weakness that are caused by an underlying health condition.

View Report: https://www.delveinsight.com/report-store/cataplexy-market

Request for Sample Report: https://www.delveinsight.com/sample-request/cataplexy-market

Scope of Cataplexy Market Report:

  • The report covers the descriptive overview of Cataplexy, explaining its causes, signs and symptoms, pathophysiology, diagnosis and currently available therapies
  • Comprehensive insight has been provided into the Cataplexy epidemiology and treatment in the 7MM
  • Additionally, an all-inclusive account of both the current and emerging therapies for Cataplexy are provided, along with the assessment of new therapies, which will have an impact on the current treatment landscape
  • A detailed review of Cataplexy market; historical and forecasted is included in the report, covering drug outreach in the 7MM
  • The report provides an edge while developing business strategies, by understanding trends shaping and driving the global Cataplexy market

Cataplexy can cause muscle weakness in any part of the body, though it commonly affects the limbs (hands may drop whatever they’re holding, knees may buckle, legs may collapse) and face (eyelids may droop, jaw may go slack and speech become slurred, the head may nod). The attacks can range from mild, such as a slight drooping of the eyelids, to severe, such as a total body collapse. Symptoms of cataplexy associated with narcolepsy often begin in childhood and young adulthood, between the ages of 7 and 25 years, but it can start at any time.

View Report: https://www.delveinsight.com/report-store/cataplexy-market

Request for Sample Report: https://www.delveinsight.com/sample-request/cataplexy-market

Cataplexy Companies covered are:

·         Axsome Therapeutics

·         Suven Life Sciences

·         Takeda

·         Avadel

·         And Many Others

Cataplexy Therapies are:

·         AXS-12

·         SUVN-G3031

·         Tak-944

·         TAK-925

·         FT218

·         And Many Others

Request for Sample Report: https://www.delveinsight.com/sample-request/cataplexy-market

View Report: https://www.delveinsight.com/report-store/cataplexy-market

Table of Contents:

1. Key Insights

2. Executive Summary of Central Nervous System Lymphoma

3. Competitive Intelligence Analysis for Central Nervous System Lymphoma

4. Central Nervous System Lymphoma: Market Overview at a Glance

5. Central Nervous System Lymphoma: Disease Background and Overview

5.1. Introduction

8. Treatment Algorithm, Current Treatment, and Medical Practices

9. Unmet Needs

10. Key Endpoints of Central Nervous System Lymphoma Treatment

11. Marketed Products

List to be continued in report

12. Emerging Therapies

List to be continued in report

13. Central Nervous System Lymphoma: Seven Major Market Analysis

14. Attribute analysis

15. 7MM: Market Outlook

16. Access and Reimbursement Overview of Central Nervous System Lymphoma

17. KOL Views

18. Market Drivers

19. Market Barriers

20. Appendix

20.1. Bibliography

20.2. Report Methodology

21. DelveInsight Capabilities

22. Disclaimer

23. About DelveInsight

Request for Detailed TOC: https://www.delveinsight.com/sample-request/cataplexy-market

Related Reports:

·         Intrahepatic Cholangiocarcinoma Market

·         Barett Esophagus Market

·         Aortic Stenosis Market

·         Chemotherapy Induced Diarrhea Market

·         Immunologic Deficiency Syndrome Market

·         Acquired Immunodeficiency Syndrome (AIDS) Market

·         Bladder pain syndrome Market

·         Cardiac Arrythmia Market

·         Cardiorenal Syndrome Market

·         Carpal Tunnel Syndrome Market

·         Central Retinal Venous Occulsion Market

·         Foot and Ankle Devices Market

About DelveInsight

DelveInsight is a premier Business Consulting and Market Research firm focused exclusively on the life science segment. With a wide array of smart end-to-end solutions, the firm helps the global Pharmaceutical and Bio-Tech companies formulate prudent business decisions for

Browse through our vast repository from here.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Ankit Nigam
Email: info@delveinsight.com
Phone: +19193216187
City: Albany
State: New York

Comments

Post a Comment

Popular posts from this blog

How Competitive intelligence is transforming the scenario for Biotech firms?

What is Competitive intelligence service? Competitive intelligence ideally means gathering information on rival business in the market, analyse the information and use the information to strategize to yield positive results. Going by the definition, competitive intelligence assembles actionable information from diverse published and unpublished sources, collected efficiently and ethically. So, analysts performing Competitive intelligence for their clienteles present a detailed picture of the marketplace, forthcoming challenges and the ways to face them, even before the can harm the client’s business. What could it mean? Competitive intelligence can often give a wrong idea, as it may misunderstood as a service which can help gain an advantage over the rivals. However, this is not the case. Competitive intelligence is an ethical and legal practise undertaken involving the study of analytical data, analysing the market and optimizing the relevant and realistic strategies t...
Read more

Cervical Intraepithelial Neoplasia Market and Epidemiology 2032 by DelveInsight

DelveInsight's " Cervical Intraepithelial Neoplasia Market Insights, Epidemiology, and Market Forecast-2032 " report delivers an in-depth understanding of Cervical Intraepithelial Neoplasia, historical and forecasted epidemiology as well as the Cervical Intraepithelial Neoplasia market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), and Japan. The Cervical Intraepithelial Neoplasia market report provides current treatment practices, emerging drugs, the market share of the individual therapies, and the current and forecasted Cervical Intraepithelial Neoplasia market size from 2019 to 2032, segmented by seven major markets. The Report also covers current Cervical Intraepithelial Neoplasia treatment practice/algorithm, market drivers, market barriers, and unmet medical needs to curate the best opportunities and assesses the underlying potential of the Cervical Intraepithelial Neoplasia market. Request for a Free Sample Report: Cervic...
Read more

The Need And The Importance Of The Healthcare Reports for the Pharma Companies

Image
It is very important for the hospitals and the other medical institutions to preserve and keep the healthcare reports of all the patients very safe and secure. All the medical records are being kept by almost all of these institutes. As a matter of fact, the healthcare reports are very important for comprehending the medical history of the patient. If he or she suffers from the same ailment once more the previous reports will be absolutely indispensible while treating him or her. Nowadays, with the advancement of technology the manual records are slowly and gradually getting digitalized. It is easier to store and preserve the digital records than the manual and the physical ones.  Choosing The Best And The Most Professional Services For Healthcare Reports: • Rising Pharma Market for You Now In the market there are a host of companies that preserves the healthcare reports of the various patients. All of it is now being done in the digital format due to the adv...
Read more